Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-02-13 12:07 pm Purchase | 2022-12-31 | 13G | Repare Therapeutics Inc. RPTX | CHI Advisors LLC | 2,800,126 6.670% | 587,870 (+26.57%) | Filing History |
| 2023-02-10 2:05 pm Sale | 2022-12-31 | 13G | Repare Therapeutics Inc. RPTX | ARK Investment Management LLC | 2,428,055 5.790% | -552,781 (-18.54%) | Filing History |
| 2023-02-09 12:31 pm Sale | 2023-02-09 | 13G | Repare Therapeutics Inc. RPTX | FMR LLC | 876,178 2.088% | -2,145,135 (-71.00%) | Filing History |
| 2023-01-06 4:19 pm Sale | 2022-12-29 | 13D | Repare Therapeutics Inc. RPTX | Versant Venture Capital V, L.P. | 2,094,451 5.000% | -250,000 (-10.66%) | Filing History |
| 2022-06-13 4:38 pm Sale | 2022-06-03 | 13D | Repare Therapeutics Inc. RPTX | Versant Venture Capital V, L.P. | 2,344,451 5.600% | -250,000 (-9.64%) | Filing History |
| 2022-06-06 5:25 pm Purchase | 2022-06-02 | 13G | Repare Therapeutics Inc. RPTX | BIOTECHNOLOGY VALUE FUND L P | 8,141,988 19.400% | 3,283,227 (+67.57%) | Filing History |
| 2022-02-14 5:07 pm Purchase | 2021-12-31 | 13G | Repare Therapeutics Inc. RPTX | Redmile Group, LLC | 2,789,496 6.700% | 141,800 (+5.36%) | Filing History |
| 2022-02-14 2:35 pm Purchase | 2021-12-31 | 13G | Repare Therapeutics Inc. RPTX | T. Rowe Price Associates, Inc. | 2,166,822 5.100% | 2,166,822 (New Position) | Filing History |
| 2022-02-14 09:00 am Sale | 2021-12-31 | 13G | Repare Therapeutics Inc. RPTX | Deep Track Capital, LP | 2,100,000 5.030% | -4,600 (-0.22%) | Filing History |
| 2022-02-11 9:11 pm Purchase | 2021-12-31 | 13G | Repare Therapeutics Inc. RPTX | BIOTECHNOLOGY VALUE FUND L P | 4,858,761 11.600% | 1,136,363 (+30.53%) | Filing History |
| 2022-02-11 11:36 am Sale | 2021-12-31 | 13G | Repare Therapeutics Inc. RPTX | CHI Advisors LLC | 2,212,256 5.300% | -319,894 (-12.63%) | Filing History |
| 2022-02-09 1:48 pm Purchase | 2021-12-31 | 13G | Repare Therapeutics Inc. RPTX | ARK Investment Management LLC | 2,980,836 7.140% | 2,980,836 (New Position) | Filing History |
| 2022-02-09 10:24 am Purchase | 2022-02-08 | 13G | Repare Therapeutics Inc. RPTX | FMR LLC | 3,021,313 7.239% | 263,938 (+9.57%) | Filing History |
| 2021-11-02 5:01 pm Sale | 2021-11-01 | 13D | Repare Therapeutics Inc. RPTX | ORBIMED ADVISORS LLC | 3,177,041 7.700% | -99,284 (-3.03%) | Filing History |
| 2021-10-29 4:33 pm Purchase | 2021-10-28 | 13G | Repare Therapeutics Inc. RPTX | Deep Track Capital, LP | 2,104,600 5.120% | 2,104,600 (New Position) | Filing History |
| 2021-08-16 4:57 pm Unchanged | 2021-08-05 | 13D | Repare Therapeutics Inc. RPTX | Versant Venture Capital V, L.P. | 2,594,451 7.000% | 0 (Unchanged) | Filing History |
| 2021-07-20 5:36 pm Sale | 2021-07-12 | 13D | Repare Therapeutics Inc. RPTX | MPM BioVentures 2014 L.P. | 3,882,485 10.500% | -396,746 (-9.27%) | Filing History |
| 2021-05-25 4:06 pm Purchase | 2021-05-24 | 13D | Repare Therapeutics Inc. RPTX | MPM BioVentures 2014 L.P. | 4,279,231 11.600% | 4,279,231 (New Position) | Filing History |
| 2021-03-22 5:49 pm Purchase | 2021-03-12 | 13D | Repare Therapeutics Inc. RPTX | MPM BioVentures 2014 L.P. | 4,672,838 12.700% | 4,672,838 (New Position) | Filing History |
| 2021-03-16 5:18 pm Purchase | 2021-03-12 | 13G | Repare Therapeutics Inc. RPTX | BIOTECHNOLOGY VALUE FUND L P | 3,722,398 10.100% | 750,207 (+25.24%) | Filing History |